Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction

Blood

Volumn 87, Issue 10, 1996, Pages 4068-4071

  Emmons, Robert V B ^a   Reid, Diane M ^b   Cohen, Robert L ^b   Meng, Gloria ^b   Young, Neal S ^b   Dunbar, Cynthia E ^b   Shulman, N Raphael ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; THROMBOPOIETIN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; THROMBOCYTOPOIESIS;

EID: 0029881744     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4068.bloodjournal87104068     Document Type: Article

References (39)

1. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
2. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
3. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
4. Bartley TD, Bogenberger J, Hunt P, Li Y-S, Lu HS, Martin F, Chang M-S, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MC-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
5. Sohma Y, Akahori H, Seki N, Hori T, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H: Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 353:57, 1994
6. Kuter DJ, Beeler DL, Rosenberg RD: The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 91:11104, 1994
7. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrum JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoetin. Nature 369:568, 1994
8. Banu N, Wang JF, Deng B, Groopraan JE, Avraham H: Modulation of megakaryocytopoiesis by thrombopoietin: The c-Mpl ligand. Blood 86:1331, 1995
9. Methia N, Louache F, Vainchenker W, Wendling F: Oligonucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395, 1993
10. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W: The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85:391, 1995
11. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW: Thrombocytopenia in c-mpl-deficient mice. Science 265:1445, 1994
12. de Sauvage FJ, Luoh S-M, Carver-Moore K, Ryan A, Dowd M, Eaton DL, Moore MW: Deficiencies in early and late stages of megakaryocytopoiesis in TPO-KO mice. Blood 86:255a, 1995 (abstr, suppl 1)
13. Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan WT, Hunt P: Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 86:971, 1995
14. Kuter DJ, Rosenberg RD: The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85:2720, 1995
15. Kuter DJ, Rosenberg RD: Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 84:1464, 1994
16. Hoffman R, Mazur E, Bruno E, Floyd V: Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med 305:533, 1981
17. Mazur EM, de Alarcon P, South K, Miceli L: Human serum megakaryocyte colony-stimulating activity increases in response to intensive cytotoxic chemotherapy. Exp Hematol 12:624, 1984
18. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J, Skrine JD, Knudten A, Chen J, Trail G, Sleeman L, Cole S, Grampp G, Hunt P: Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 95:2973, 1995
19. Chang M, Suen Y, Meng G, Buzby J, Williams S, Shen V, Knoppel A, Fernandez G, Cairo MS: Regulation of TPO mRNA expression and protein production: TPO gene regulation appears post transcriptional, and endogenous levels are inverseley correlated to megakaryocyte mass and circulating platelet count. Blood 86:368a, 1995 (abstr, suppl 1)
20. Miura M, Jackson CW, Steward SA: Increase in circulating megakaryocyte growth-promoting activity (Meg-GPA) following sub-lethal irradiation is not related to decreased platelets. Exp Hematol 16:139, 1988
21. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJM, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995
22. Young NS, Alter BF: Aplastic Anemia, Acquired and Inherited. Philadelphia, PA, W.B. Saunders, 1994
23. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85:3058, 1995
24. Heyns AduP, Badenhorst PN, Wessels P, Pieters H, Kotze HF, Letter MG: Indium-111-labelled human platelets: A method for use in severe thrombocytopenia. Thromb Haemost 52:226, 1984
25. Pearson HA, Shulman NR, Oski FA, Eitzman DV: Platelet survival in Wiskott-Aldrich syndrome. J Pediatrics 68:754, 1966
26. Grottum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M: Wiskott-Aldrich syndrome: Qualitative platelet defects and short platelet survival. Br J Haematol 17:373, 1969
27. Kalmaz GD, McDonald TP: Effects of antiplatelet serum and thrombopoietin on the percentage of small acetylcholinesterase-positive cells in bone marrow of mice. Exp Hematol 9:1002, 1981
28. Evatt BL, Shreiner DP, Levin J: Thrombopoietic activity of fractions of rabbit plasma: Studies in rabbits and mice. J Lab Clin Med 83:364, 1974
29. Hill RJ, Levin J: Regulators of thrombopoiesis: Their biochemistry and physiology. Blood Cells 15:141, 1989
30. McDonald TP, Cottrell M, Clift R: Hematologic changes and thrombopoietin production in mice after X-irradiation and platelet-specific antisera. Exp Hematol 5:291, 1977
31. Ebbe S, Phalen E, Threatte G, Londe H: Modulation of radiation-induced hemopoietic suppression by acute thrombocytopenia. Ann NY Acad Sci 459:179, 1985
32. Hunt P, Li Y-S, Nichol JL, Hokom MM, Bogenberger JM, Swift SE, Skrine JD, Hornkohl AC, Lu H, Clogston C, Merewether LA, Johnson MJ, Parker V, Knudten A, Farese A, Hsu RY, Garcia A, Stead R, Bosselman RA, Bartley TD: Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 86:540, 1995
33. Odell TT Jr, McDonald TP: Life span of mouse blood platelets. Proc Soc Exp Biol Med 106:107, 1961
34. Ebbe S, Baldini M, Donovan J: Comparative studies of plate-let survival by different methods in the rabbit. Blood 25:548, 1965
35. Shulman NR, Marder VJ, Weinrach RS: Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic, and isotopic studies. NY Acad Sci 124:499, 1965
36. Aster RH, Keene WR: Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol 16:61, 1969
37. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K: Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86:3668, 1995
38. Fielder PJ, Hass P, Nagle M, Stefanich E, Widmer R, Keller G, Eaton D: Human platelets as a model for the binding, internalization, and degradation of thrombopoietin (TPO). Blood 86:365a, 1995 (abstr, suppl 1)
39. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ: Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80:33, 1987